Table 3.
Comparison of clinical indications and characteristics of the patient population who underwent bariatric surgery
| Country | Cohort | BMI level with no comorbidities | BMI level with at least comorbidity | Prevalence of comorbidities | |||
|---|---|---|---|---|---|---|---|
| T2DM | Hypertension | OSA | Knee osteoarthritis | ||||
| Belgium | Indication | 40 | 35 | Yes | Yes | Yes | No |
| Real cohort | 38 | 9 % | 28 % | 3 % | NA | ||
| Denmark | Indication | 40/50 | 35 | Yes | Yes | Yes | Yes |
| Real cohort | 45 | 23 % | 32 % | 11 % | NA | ||
| England | Indication | 40/50 | 35 | Yes | Yes | Yes | Yes |
| Real cohort | 50.6 | 24 % | 32 % | 16 % | 53 % | ||
| France | Indication | 40 | 35 | Yes | Yes | Yes | Yes |
| Real cohort | 43.7 | 10 % | 22 % | 12 % | NA | ||
| Germany | Indication | 40 | 35 | Yes | Yes | No | No |
| Real cohort | 48.8 | 20 % | 57 % | 21 % | 44 % | ||
| Italy | Indication | 40 | 35 | Yes | Yes | No | Yes |
| Real cohort | 46.2 | NA | NA | NA | NA | ||
| Sweden | Indication | 40 | 35 | Yes | No | Yes | Yes |
| Real cohort | 42.8 | 18 % | 43 % | 9 % | NA | ||
BMI body mass index, NA not available, OSA obstructive sleep apnea, T2DM type 2 diabetes